RORα-Mediated Purkinje Cell Development Determines Disease Severity in Adult SCA1 Mice

217Citations
Citations of this article
161Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Spinocerebellar ataxia type 1 (SCA1) is one of nine inherited, typically adult onset, polyglutamine neurodegenerative diseases. To examine whether development impacts SCA1, we used a conditional transgenic mouse model of SCA1 to delay the postnatal expression of mutant ATXN1 until after completion of cerebellar development. Delayed postnatal expression of mutant ATXN1 led to a substantial reduction in severity of disease in adults in comparison with early postnatal gene expression. This was linked to a destabilization of RORα, a transcription factor critical for cerebellar development. In SCA1 mice, there was a depletion of RORα and a reduction in expression of genes controlled by RORα. Partial loss of RORα enhanced mutant ATXN1 pathogenicity. Additionally, evidence points to the existence of a complex containing ATXN1, RORα, and the RORα coactivator Tip60. These studies indicate RORα and Tip60 have a role in SCA1 and suggest a mechanism by which compromising cerebellar development contributes to severity of neurodegeneration in an adult. © 2006 Elsevier Inc. All rights reserved.

Cite

CITATION STYLE

APA

Serra, H. G., Duvick, L., Zu, T., Carlson, K., Stevens, S., Jorgensen, N., … Orr, H. T. (2006). RORα-Mediated Purkinje Cell Development Determines Disease Severity in Adult SCA1 Mice. Cell, 127(4), 697–708. https://doi.org/10.1016/j.cell.2006.09.036

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free